Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Dyne Therapeutics Inc (DYN)

Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Dyne Therapeutics Inc. is a muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The company's proprietary platform includes FORCE(TM). Dyne Therapeutics Inc. is based in WALTHAM, Mass.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Mar, 2026 Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025
Sales 0 0 0 0 0
Sales Growth unch unch unch unch unch
Net Income -120,850 -111,960 -108,040 -110,860 -115,360
Net Income Growth -7.94% -3.63% +2.54% +3.90% -28.84%

Balance Sheet

(Values in U.S. Thousands) Mar, 2026 Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025
Total Assets 1,079,950 1,186,960 867,060 728,990 721,070
Total Assets Growth -9.02% +36.89% +18.94% +1.10% +4.32%
Total Liabilities 214,900 214,830 175,280 157,550 52,100
Total Liabilities Growth +0.03% +22.56% +11.25% +202.40% -15.15%

Cash Flow

(Values in U.S. Thousands) Mar, 2026 Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025
Operating Cash Flow -144,920 -403,210 -291,380 -200,600 -105,890
Operating Cash Flow Growth +64.06% -38.38% -45.25% -89.44% +63.78%
Net Cash Flow -140,250 458,350 138,230 49,650 36,810
Change in Net Cash Flow -130.60% +231.59% +178.41% +34.88% -88.26%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.